Long-term safety in patients with recurrent ovarian cancer treated with niraparib versus placebo: Results from the phase III ENGOT-OV16/NOVA trial.
Saved in:
| Title: | Long-term safety in patients with recurrent ovarian cancer treated with niraparib versus placebo: Results from the phase III ENGOT-OV16/NOVA trial. |
|---|---|
| Authors: | Mirza, Mansoor R.1 (AUTHOR) mansoor@rh.regionh.dk, Benigno, B.2 (AUTHOR), Dørum, A.3 (AUTHOR), Mahner, S.4 (AUTHOR), Bessette, P.5 (AUTHOR), Barceló, I. Bover6 (AUTHOR), Berton-Rigaud, D.7 (AUTHOR), Ledermann, J.A.8 (AUTHOR), Rimel, B.J.9 (AUTHOR), Herrstedt, J.10,11 (AUTHOR), Lau, S.12 (AUTHOR), du Bois, A.13 (AUTHOR), Herráez, A. Casado14 (AUTHOR), Kalbacher, E.15 (AUTHOR), Buscema, J.16 (AUTHOR), Lorusso, D.17 (AUTHOR), Vergote, I.18 (AUTHOR), Levy, T.19 (AUTHOR), Wang, P.20 (AUTHOR), de Jong, F.A.21 (AUTHOR) |
| Source: | Gynecologic Oncology. Nov2020, Vol. 159 Issue 2, p442-448. 7p. |
| Database: | Academic Search Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 146535408 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Long-term safety in patients with recurrent ovarian cancer treated with niraparib versus placebo: Results from the phase III ENGOT-OV16/NOVA trial. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Mirza%2C+Mansoor+R%2E%22">Mirza, Mansoor R.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<i> mansoor@rh.regionh.dk</i><br /><searchLink fieldCode="AR" term="%22Benigno%2C+B%2E%22">Benigno, B.</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Dørum%2C+A%2E%22">Dørum, A.</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Mahner%2C+S%2E%22">Mahner, S.</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Bessette%2C+P%2E%22">Bessette, P.</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Barceló%2C+I%2E+Bover%22">Barceló, I. Bover</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Berton-Rigaud%2C+D%2E%22">Berton-Rigaud, D.</searchLink><relatesTo>7</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Ledermann%2C+J%2EA%2E%22">Ledermann, J.A.</searchLink><relatesTo>8</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Rimel%2C+B%2EJ%2E%22">Rimel, B.J.</searchLink><relatesTo>9</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Herrstedt%2C+J%2E%22">Herrstedt, J.</searchLink><relatesTo>10,11</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Lau%2C+S%2E%22">Lau, S.</searchLink><relatesTo>12</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22du+Bois%2C+A%2E%22">du Bois, A.</searchLink><relatesTo>13</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Herráez%2C+A%2E+Casado%22">Herráez, A. Casado</searchLink><relatesTo>14</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Kalbacher%2C+E%2E%22">Kalbacher, E.</searchLink><relatesTo>15</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Buscema%2C+J%2E%22">Buscema, J.</searchLink><relatesTo>16</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Lorusso%2C+D%2E%22">Lorusso, D.</searchLink><relatesTo>17</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Vergote%2C+I%2E%22">Vergote, I.</searchLink><relatesTo>18</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Levy%2C+T%2E%22">Levy, T.</searchLink><relatesTo>19</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Wang%2C+P%2E%22">Wang, P.</searchLink><relatesTo>20</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22de+Jong%2C+F%2EA%2E%22">de Jong, F.A.</searchLink><relatesTo>21</relatesTo> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Gynecologic+Oncology%22">Gynecologic Oncology</searchLink>. Nov2020, Vol. 159 Issue 2, p442-448. 7p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=146535408 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.ygyno.2020.09.006 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 7 StartPage: 442 Titles: – TitleFull: Long-term safety in patients with recurrent ovarian cancer treated with niraparib versus placebo: Results from the phase III ENGOT-OV16/NOVA trial. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Mirza, Mansoor R. – PersonEntity: Name: NameFull: Benigno, B. – PersonEntity: Name: NameFull: Dørum, A. – PersonEntity: Name: NameFull: Mahner, S. – PersonEntity: Name: NameFull: Bessette, P. – PersonEntity: Name: NameFull: Barceló, I. Bover – PersonEntity: Name: NameFull: Berton-Rigaud, D. – PersonEntity: Name: NameFull: Ledermann, J.A. – PersonEntity: Name: NameFull: Rimel, B.J. – PersonEntity: Name: NameFull: Herrstedt, J. – PersonEntity: Name: NameFull: Lau, S. – PersonEntity: Name: NameFull: du Bois, A. – PersonEntity: Name: NameFull: Herráez, A. Casado – PersonEntity: Name: NameFull: Kalbacher, E. – PersonEntity: Name: NameFull: Buscema, J. – PersonEntity: Name: NameFull: Lorusso, D. – PersonEntity: Name: NameFull: Vergote, I. – PersonEntity: Name: NameFull: Levy, T. – PersonEntity: Name: NameFull: Wang, P. – PersonEntity: Name: NameFull: de Jong, F.A. IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 11 Text: Nov2020 Type: published Y: 2020 Identifiers: – Type: issn-print Value: 00908258 Numbering: – Type: volume Value: 159 – Type: issue Value: 2 Titles: – TitleFull: Gynecologic Oncology Type: main |
| ResultId | 1 |